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SUMMARY
Antibodies to neutrophil cytoplasmic antigens (ANCA) are good serological markers for patients
with mainly vasculitic conditions. Two main types ofANCAs have been detected, the first termed
cytoplasmicantineutrophilcytoplasmicantibody(cANCA)aremainlyassociatedwithpatientswith
Wegener's granulomatosis, the other termed perinuclear antineutrophil cytoplasmic antibody
(pANCA)aremainlyassociatedwithpatientswithrenalvasculitis,rheumaticandcollagendisorders.
These antibodies are against various constituents of neutrophil granules. In patients with
myelodysplasia, defects in normal granulocyte development are seen. We report a series oftwelve
patientswithmyelodysplasiaofwhomatleastfourshowedalowtitreandoneahightitreofpANCA.
Twoofthesepatients alsohaddemonstrableactivityagainstmyeloperoxidase (MPO).Noneofthese
patients hadanyevidenceofsystemic orcutaneous vasculitisorofanyautoimmune disorder. There
was no pANCA positivity in an age matched control group.
INTRODUCTION
Themyelodysplasticconditionsareaheterogenous
group of haematological disorders characterised
byrefractorycytopenias. Theyincludequantitative
and qualitative abnormalities of the myeloid cell
lineage resulting in reduced chemotaxis,
phagocytosis and enzyme content.",2 In the 1980s
autoantibodies directed against the cytoplasmic
constituents of neutrophils (ANCA) were
discovered. Many oftheantigens werefound to be
enzymes normally containedwithintheneutrophil
granules, these include myeloperoxidase,
proteinage3,elastase,lactoferrinandcathepsinG.'
At least two types ofANCAs canbe distinguished
by indirect immunofluorescence on ethanol fixed
neutrophils: cytoplasmic(cANCA)andperinuclear
(pANCA). Associations have been shown to exist
between the occurrence of these antibodies and
various vasculitic disorders such as cANCA with
Wegener's granulomatosis and microscopic
polyarteritis, and pANCA with renal vasculitis as
well as various rheumatic and collagen vascular
disorders.4
This study was undertaken to look into the
occurrenceofantineutrophilcytoplasmic antibody
activity in myelodysplasia.
SUBJECTS AND METHODS
Twelve patients with an established diagnosis of
myelodysplasiaaccordingtotheFrench-American
-British(FAB)classification,5 hadtheirseratested
for ANCA by indirect immunofluorescence
according to the method described by Wiik6 at the
1stInternationalWorkshoponANCAasdidtwelve
healthy controls. Briefly, serum samples were
screened forANCA atdilutions of 1 in 10 and 1 in
20, and ifpositive titrated until endpoint. 80pl of
appropriate dilution was incubated at room
temperature for 30 minutes on ethanol fixed
neutrophil cytospins and dryed before use. After
washing in PBS (Phosphate Buffered Saline)
antihuman globulin conjugate (Dako UK, Ltd.)
was added and incubated for a further 30 minutes
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TABLE
Details ofpatient group
Case Diagnosis Age in pANCA' MPO' pANCA2 MpO2
years
1. RA 83 - <15% - 20%
2. RA 90 20 <15% 10 <15%
3. RAEB 81 20 <15% 20 <15%
4. RAEB 72 - <15% - <15%
5. RAEB 78 - <15% 20 <15%
6. RAEB 79 - <15% - <15%
7. RAEB 78 20 16% 10 16%
8. RA 71 160 <15% NOT AVAILABLE
9. RAEB 78 20 <15% 20 <15%
10. RAEB 70 - <15% 10 <15%
11. RA 54 - <15% - <15%
12. RARS 64 - <15% - <15%
ABBREVIATIONS:
RA Refractory anaemia
RAEB Refractory anaemia with excess blasts
RARS Refractory anaemia with ring sideroblasts
at room temperature. Ifrequired reincubation was
performed with antihuman IgG and IgM (Dako
UK, Ltd.) to determine immunoglobulin class
specificity. The slides were then washed in PBS,
mounted and viewed using a fluorescence
microscope.
Serum containing pANCA was recognised as a
non-granularperinuclear ornuclearstaining ofthe
neutrophils. A cANCA pattern was recognised by
a granular cytoplasmic staining. If positive for
either p or cANCA the serum was titrated until an
end point was obtained. Sera from patients with
antinuclearantibody(ANA)alsoexhibitapANCA
pattern therefore all positive sera were tested for
ANA by indirect immunofluorescence. All serum
samples were also tested for the presence of
antimyeloperoxidase antibodies (MPO)byELISA
(BiodiagnosticsLtdEngland),Positivitywastaken
as greater than 15% ofpositive standard, and for
thepresenceofanti-nucleolar, anti-mitochondrial,
anti-smooth muscle and anti-gastric parietal cell
antibodies by the indirect immunofluorescence
technique.
Patientswereretestedafteranintervalof2-6months
where possible.
A control group of healthy people from a similar
age group was also tested.
RESULTS
Sera from 5 out ofthe 12 patients studied showed
titresforpANCAoninitialtesting;afurtherpatient
negative on initial testing was positive on repeat
testing. Nopatients showedpositivityforcANCA,
antinuclear antibody or other autoantibodies. One
patient had borderline activity against
myeloperoxidase initially, two patients were
positive on repeat testing. The details are given in
the table. In the control group no cases showed
positivityforpANCAthoughtwohaddemonstrable
cANCA activity; all were negative for
antimyeloperoxidase activity.
DISCUSSION
We have shown positive titres for pANCA in at
least 5 out of 12 patients with myelodysplasia and
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none in a control group of similair age. There is a
strongassociationbetween ANCA inhightitre (80
or greater) and many vasculitic diseases. There
have been a few reports ofan association between
myelodysplasiaandvariousvasculitides,7'8butnone
of our patients showed any clinical or laboratory
evidence ofsystemic or cutaneous vasculitis or of
any autoimmune disorder.
The pathophysiological significance of ANCA,
especially in low titre, is uncertain. Arecent study
has shown that a wide range ofconditions can be
associated with low ANCA titre, especially
pANCA. Many of these cases did not show any
evidence ofvasculitis.9 Certain experimental data
suggest that ANCAs do play a role in the
pathogenesisofvasculitis.10Stimulatedneutrophils
expressanumberofmolecules,includingneutrophil
granule enzymes at their surface. It has been
suggested that ANCAs react with these surface
enzymes to further activate neutrophils into
producingreactiveoxygen specieswiththefurther
releaseoflysosomalenzymesleadingtovasculitis.
Patientswithmyelodysplasiahavereducednumbers
of abnormal neutrophils and are at an increased
tendency to infection.11 In short term culture
granulocyte-macrophage colony forming units
(CFU-GM) are reduced and abnormal,12 so
indicating that there is a defect in neutrophil
development.Wehavediscoveredthatinthisgroup
low titres of pANCA are present, this in contrast
withthecontrolgroupwherepANCAwasnotdetected.
We postulate that the abnormal neutrophils in
myelodysplasia may lead to exposure ofabnormal
constituents to the host immune system thereby
stimulating antibody formation.
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